The susceptibility of swine to infection with encephalomyocarditis virus (EMCV) was assessed. Transmission of EMCV in a single exposure by gavage or intranasal routes was highly dose dependent. In a direct comparison, animals were exposed to EMCV by gavage, intranasal, intramuscular, intratracheal, or transdermal routes. A higher proportion of animals exposed by transdermal (5/5), intratracheal (5/5), or intramuscular (5/5) routes than those exposed by intranasal (2/5) or gavage (3/5) routes became infected. The large quantity of virus required to infect animals intranasally or orally suggests that transmission by these routes may not occur routinely in the field. Transmission of EMCV by wound contamination (transdermally) has not been reported previously. Although EMCV was recovered from rectal, external genitalia, and pharyngeal swabs, there was no evidence of pig-to-pig transmission of EMCV from experimentally infected animals to comingled sentinels.
Encephalomyocarditis virus (EMCV) infection is not uncommon in swine in the United States and elsewhere in the world. 8, 9, 13, 16, 17 In a survey of 104 swine herds located in Iowa, 13.8% of breeding stock and 8.5% of finishers had serum neutralizing antibodies against EMCV. Approximately 90% of herds had 1 or more animals with antibody titers. 19 Other serosurveys have reported similar, or higher, prevalence in swine populations. 8,9,13,15 The transmission mechanism of EMCV into swine herds is not known, although rodents are often assumed to be involved. 10 However, in a serosurvey of 356 free-living animals captured on 20 commercial swine farms, 2/74 (2.7%) domestic cats (Felis domestica), 0/203 house mice (Mus musculus), 0/15 mice of genus Peromyscus, 0/9 brown rats (Rattus norvegicus), 0/34 opossums (Didelphis virginiana), 0/14 raccoons (Procyon lotor), and 0/7 striped skunks (Mephitis mephitis) were seropositive for EMCV. 15 Among 267 sows and gilts tested on these same 20 farms, 67/267 (25.1%) had serum neutralizing antibody titers ≥ 1:16, 42/267 (15.7%) had antibody titers ≥ 1:32, and 28/267 (10.5%) had antibody titers 21:64. The preponderance of seropositive swine relative to other species tested indicated that swine, or some species not included in the survey, were the natural reservoirs of EMCV.
Within EMCV-infected herds, transmission of the virus among animals has been assumed to be fecal-oral despite the fact that experimental studies have shown that transmission to uninfected, comingled animals by contact with infected animals and their feces is not very efficient. In one study, only 2 of 18 uninfected female mice placed in contact with 204 infected female mice in highly overcrowded conditions became infected. Exposure of 18 uninfected male mice to 198 infected male mice resulted in 13 infected animals. The higher incidence in the males was credited to fighting and cannibalism in the group. 5 In a similar experiment in swine, transmission by contact was attempted in 2 groups of 4 pigs each. 11 Two animals in each group were orally exposed to EMCV. None of the contact animals became infected. However, EMCV can be transmitted from sows to their nursing offspring, although whether transmission occurs via the milk or via fecal contamination has not been determined. 3 The purpose of this study was to acquire new information relating to the transmission of EMCV to swine. Specifically, the intent of this project was to examine the effects of challenge dose and route of exposure on the infectivity of EMCV for swine. Two experiments were performed. In the first, different challenge doses were administered by gavage or intranasal exposure. The data from this experiment were then used to set the challenge dose in the second experiment. In the second experiment, a single EMCV challenge dose was administered by five different exposure routes. Both EMCV isolates were grown using standard virus cultivation methods in a baby hamster kidney (BHK-21) cell line in 150-cm 2 single-use cell culture flasks. c Minimum essential medium d (MEM) with 10% fetal bovine serum (FBS), tryptose phosphate broth (4 ml/liter), sodium bicarbonate (2.2 g/liter), and gentamicin sulfate (0.5 mg/100 ml) was used for cell growth. After 48 hr, flasks were freeze-thawed once, decanted into 50-ml conical centrifuge tubes, e and centrifuged at 3,000 x g for 20 min. Virus concentration (TCID 50 / ml) was determined by the Karber method using a series of 10-fold dilutions. 14 Animals. Four-to 6-wk-old conventional swine were used in the two experiments. Animals were derived from a commercial herd with no history or clinical signs compatible with EMCV infection. Prior to the commencement of experimental work, all animals were negative (≤ 1:8) for antibodies against EMCV on 2 tests spaced at least 7 days apart.
Materials and methods
Blood samples. Blood samples were taken from the anterior vena cava using a single-use collection system. f Serum samples were stored at -20 C until assayed by the serum virus neutralization (SN) test.
Microtitration SN test. The SN test was done using 1:2 serial dilutions of heat-inactivated serum in 96-well flat-bottom culture plates. g The challenge virus (EMCV-NVSL) was pretitered and diluted with MEM plus gentamicin sulfate (0.5 mg/100 ml) to deliver between 100 and 300 TCID 50 /ml. The virus-serum solution was incubated at 20-22 C for 60 min, after which 0.15 ml of a suspension containing 3-5 x 10 5 BHK-21 cells/ml in a solution of MEM with 10% FBS, tryptose phosphate broth (4 ml/liter), sodium bicarbonate (2.2 g/liter), and gentamicin sulfate (0.5 mg/100 ml) was added to each well. Plates were then incubated at 37 C in a 5% CO 2 environment for 48 hr and observed for cytopathic (CPE) effects using an inverted light microscope. The antibody titer was read as the highest serum dilution resulting in complete virus neutralization, as indicated by the absence of CPE.
Virus isolation. In experiment 2, rectal, pharyngeal, and urogenital (preputial or vulvar) samples were taken for virus isolation. Cotton-tipped applicators h were dampened before swabbing in a medium consisting of Earle's balanced salt solution i containing gentamicin sulfate (0.5 mg/500 ml) and amphotericin B (1 mg/500 ml), pH (6.8-7.2) balanced with sodium bicarbonate. Immediately after swabbing, applicators were agitated briskly in the medium then broken off, leaving the cotton tips in 2 ml of the solution. Samples were frozen at -20 C until tested.
For isolation, BHK-21 cells were grown in 24-well tissue culture plates j using MEM with 10% FBS, tryptose phosphate broth (4 ml/liter), sodium bicarbonate (2.2 g/liter), and gentamicin sulfate (0.5 mg/ 100 ml). Cells were considered acceptable for isolation at 90-100% confluency (24-48 hr). To control for bacterial contamination, fecal samples were centrifuged at 3,000 x g for 20 min and filtered with a 0.45-µm syringe filter k prior to the isolation assay. Growth medium was removed, and 0.2 ml of sample was placed in each well. Plates were incubated for 1 hr at 37 C under 5% CO 2 then were flooded with MEM containing gentamicin sulfate (0.5 mg/500 ml) and amphotericin B (1 mg/500 ml). This solution was then removed and replaced with MEM containing gentamicin sulfate (0.5 mn/500 ml). amphotericin B (1 mn/500 ml), and 2% FBS. Wells were observed daily for CPE. After 6 days, and in the absence of CPE, plates were freeze-thawed twice and passed directly onto a new set of 24-well plates with 90-100% confluent 24-48 hr-old BHK-21 cells. In some cases, the process was repeated for a third passage. Samples exhibiting CPE characteristic of EMCV were positively identified using a direct fluorescent antibody conjugate. b EMCVpositive samples were subsequently submitted for independent confirmation. 1 Challenge routes. Pigs were exposed to EMCV by one of 5 routes: intranasal (IN), gavage (GA), intratracheal (IT), intramuscular (IM), or transdermal (TD). Intramuscular exposure was intended to function as the positive control. Other routes were intended to represent "natural" exposure. For GA exposure, a 3/8-inch (~ 1 -mm) resilient plastic orogastric tube was introduced into the stomach. The challenge virus was injected into the tubing followed by a flush of 20 ml phosphate-buffered saline solution (PBS) with 1% (w/v) mucin. m Prior to withdrawal, the tube was evacuated with 10 ml of air. For TD exposure, the inner portion of 1 ear was wiped clean, punctured with a 50-pin tattoo pliers, n and swabbed with virus. Excess inoculum was removed with an absorbent towel, and the ear was covered with tape to avoid exposure of penmates to EMCV remaining on the epidermis. For intratracheal exposure, a flexible plastic tube was placed in the trachea and 0.25 ml solution of virus was introduced, followed by a 0.5-ml PBS flush. The tube was cleared with air prior to withdrawal.
Experimental design
Experiment I. Pigs were exposed to EMCV by 1 of 2 routes (GA or IN). Three virus challenge levels were administered via GA (1 x 10 5.8 TCID 50 , 1 x 10 7.8 TCID 50 , 1 x 10 10.3 TCID 50 ), and 2 exposure levels were administered IN (1 x 10 5.8 TCID 50 , 1 x 10 7.8 TCID 50 ). Subjects exposed via GA were held off feed for 12 hr prior to inoculation and fed immediately after exposure. Blood samples were obtained from pigs on days 0, 7, and 21 and tested for antibodies against EMCV by the SN test to determine if infection had occurred.
Experiment 2. Thirty-five 6-wk-old pigs were apportioned to 6 groups: 5 treatment groups of 5 pigs each and 1 negative control group of 10 animals. Each treatment group represented a route of exposure (IN, GA, IT, IM, or TD). The virus challenge dose was 1 x 10 8.80 TCID 50 for each route, with the exception of the TD pigs. It was not possible to calculate the exact EMCV exposure for the TD group because the majority of the virus solution remained on the epidermis. Negative control animals received EMCV-free tissue culture homogenate IM. All pigs were held off feed for 12 hr prior to exposure and given access to feed immediately afterwards. Three days after inoculation, 1 negative control pig was comingled with each experimental group. Serum samples were collected on days -7, 0, 4, 7, 14, 21, 28, and 36 and assayed for antibodies against EMCV by the SN test. Samples for virus isolation were collected and processed on days 0, 4, 6, 9, 12, 15, and 18. On day 29, a complete necropsy was performed on 1 animal randomly selected from among the antibody-positive pigs in each of the 5 treatment groups and 1 animal from the negative control group. Sections of brain. heart, liver, kidney, and lung were immersed in 10% formalin, processed routinely, stained with hematoxylin and eosin, and examined microscopically.
Results
Serum neutralizing antibody titers of 1:8 were considered positive for EMCV infection if the succeeding sample also tested ≥ 1:8. Antibody titers ≥ 1:16 were considered unequivocally positive. 18 For the most part, classification of infection status was relatively straightforward on this basis. All animals in both experiments had antibody titers ≤ 1:2 prior to exposure, and all negative control animals (n = 5) and comingled animals (n = 5) in experiment 2 had titers ≤ 1:2 at all samplings. In no case was virus isolated from an animal with an antibody titer ≤ 1:2. Experiment 1. EMCV infection was associated with the quantity of virus in the inoculum (Table 1) . Of GA animals, 0/5 animals seroconverted at the low exposure dose (1 x 10 5.8 TCID 50 ), 1/6 animals serocon-verted at the medium dose (1 x 10 7.8 TCID 50 ), and 4/6 seroconverted at the high dose (1 x 10 10.3 TCID 50 ). Of IN animals, 0/5 animals seroconverted at the low dose and 0/6 seroconverted at the medium dose. Because of these results, a high challenge dose was used in experiment 2. Experiment 2. One or more swine in each of the 5 exposure groups became infected with EMCV after receiving a challenge dose of 1 x 10 8.80 TCID 50 (Table  2) . Intramuscular exposure was used as a positive control. All animals in the IM, TD, and IT groups became infected. All experimental animals in these groups were seropositive by day 7 or earlier. As noted previously, the TD animals actually received less virus than did animals in the other experimental groups. Table 3 . Isolation of EMCV from swine exposed by various only the cardiac lesions were considered consistent with routes (experiment 2). those reported for EMCV infection.
or IN routes in a single exposure was highly dose dependent. The large quantity of virus required to infect animals IN or GA suggests that IN or oral transmission may be a rare event in the field. The likelihood of A smaller proportion of animals became infected in the IN (2/5) and GA (3/5) groups. Relative to the IM, TD, and IT groups, antibody response was slower and antibody titers lower in the IN and GA groups. In the GA group, pig no. 1 did not become serologically positive until day 14, and pig no. 3 became positive on day 21. In IN pig no. 1, antibody titer of 1:8 on day 4 was followed by 4 samples with titers < 1:8. This pig was apparently EMCV negative through day 29, but on day 36, EMCV response was positive, with a neutralizing antibody titer of 1:32. animals in a approaching natural setting receiving those used in this study is ticular, these result of the virus among Intratracheal or TD routes of transmission. exposure levels remote. In parimply that fecal-oral transmission wine is unlikely to occur routinely. exposure were more Intratracheal exposure to introduce virus directly into the occur in nature through exposure efficient was used lung, such as might to aerosol EMCV.
Virus was isolated from 1 or more pigs in each exposure group (Table 3) . Isolation was positive from a total of 7/25 experimentally exposed animals: rectal swabs from 3, pharyngeal swabs from 3, and preputial or vulvar swabs from 5. The possibility of contamination of external genitalia with EMCV-contaminated feces could not be eliminated, although vulvar swabs were positive from 2 animals in groups from which all swabs from other anatomical sites and all other animals were negative. Isolation attempts from negative controls, commingled animals, or seronegative experimental animals were negative.
Experimental IN aerosolization of virus has produced infection. 11 The persistence of infectious EMCV in aerosols has also been described. 1, 2 Aerosolized EMCV retained high levels of infectivity at relative humidities > 75% and < 40% and degraded rapidly at midrange relative humidity values. However, aerosol transmission of EMCV among pigs has not been reported under experimental or field conditions. Furthermore, the low within-herd prevalence observed in EMCV-positive herds in Iowa is not compatible with a hypothesis of aerosol transmission. 19 No overt clinical signs attributable to EMCV infection were observed in any animals. On day 29, 1 seropositive animal was sacrificed from each group. At necropsy, no gross pathologic changes were observed in any pigs. Two pigs (GA pig no. 4; IT pig no. 2) had several foci of mild lymphocytic cuffing of small blood vessels in the myocardium. Neither myocardial degeneration nor fibrosis was observed in the myocardium of either pig. Intratracheally inoculated pig no. 2 also had mild, patchy perivascular lymphocytic cuffing of the small airways in the lung. Intramuscularly infected pig no. 1 had infrequent foci of inflammatory aggregates consisting of macrophages, lymphocytes, and neutrophils in the liver parenchyma. No other microscopic lesions were observed. Although nonspecific, There are no previous reports of TD transmission. Transdermal exposure was intended to simulate the wounds produced by fighting among pigs. Superficial cuts and lacerations, particularly on the ears and neck, are a common outcome of such conflicts. Tattoo pliers made it possible to produce a uniform "wound" in a nearly painless fashion in each pig in the exposure group. Transdermally exposed animals received less virus than did animals in other groups because the majority of virus remained on the skin, but all animals rapidly seroconverted.
Opportunities for TD exposure by contamination of superficial wounds with EMCV exist in the field. EMCV has been recovered from the environment in association with a clinical outbreak in swine. 7 In this study, EMCV was recovered from rectal, external genitalia, and pharyngeal swabs. Previous studies have reported isolation from swine feces. 4, 6 Relative to most viruses, EMCV is extremely stable in the environment. Virus
Discussion
In these experiments, given sufficient virus swine were susceptible to EMCV infection by all routes tested. In a direct comparison using a uniform challenge dose, a higher proportion of animals exposed to EMCV by TD, IT, or IM routes than those exposed by IN or GA routes became infected. Intramuscular exposure was included as a positive control and resent a likely field exposure. Infection does not by either rep-GA persistence times of 10 days at 37 C, 21 days at 25 C, and more than 73 days at 4 C have been reported. 12 There was no evidence of pig-to-pig transmission of EMCV. Although EMCV was recovered from 1 or more experimentally infected animals in each group during the time a seronegative sentinel animal was present, all commingled pigs remained seronegative. This result is compatible with those of earlier reports 11 and represents the crux of the problem faced in understanding the epidemiology of this virus.
Swine have been shown to be susceptible to EMCV infection by several routes in this and previous studies. This study added a transdermal route to those routes of exposure previously reported. Some of these routes of transmission are probably unimportant in the epidemiology of the disease. Either the route is unnatural or the dose required to produce infection is unlikely to be encountered in the field setting. The results of this and previous studies indicate that the transmissibility of EMCV among swine is low. Control of EMCV in commercial swine herds with perceived EMCV-related disease problems may be possible through changes in management practices designed to improve hygiene, reduce disease transmission, and avoid stress.
